The administration of the cannabinoid CB1 receptor antagonist AM-251 blocked the anxiolytic and sedative actions of benzodiazepines

被引：0
|
作者：
Navarro, D. V. [1 ]
Sanguino, E. [1 ]
Manzanares, J. [1 ]
机构：
[1] Univ Miguel Hernandez, CSIC, Inst Neurociencias Alicante, Alicante, Spain
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2006年 / 16卷
关键词：
D O I：
10.1016/S0924-977X(06)70196-1
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S239 / S239
页数：1
相关论文
共 50 条
  • [1] The cannabinoid CB1 receptor is involved in the anxiolytic, sedative and amnesic actions of benzodiazepines
    Garcia-Gutierrez, Maria S.
    Manzanares, Jorge
    [J]. JOURNAL OF PSYCHOPHARMACOLOGY, 2010, 24 (05) : 757 - 765
  • [2] The Effect of CB1 Cannabinoid Receptor Antagonist AM-251 on Spike Wave Discharges in WAG/Rij Rat
    Aygun, Hatice
    Arslan, Gokhan
    Ayyildiz, Mustafa
    Agar, Erdal
    [J]. ACTA PHYSIOLOGICA, 2015, 215 : 46 - 46
  • [3] Role of Cannabinoid CB1 Receptor AM-251 in Proconvulsant Effect of Apelin Experimental Epileptiform Activity Generated with Penicillin
    Sen, Fatma Banu
    Ucar, Durmus
    Ayyildiz, Mustafa
    Agar, Erdal
    [J]. ACTA PHYSIOLOGICA, 2015, 215 : 95 - 95
  • [4] Anxiogenic profile of AM-251, a selective cannabinoid CB1 receptor antagonist, in plus-maze-naive and plus-maze-experienced mice
    Rodgers, RJ
    Evans, PM
    Murphy, A
    [J]. BEHAVIOURAL PHARMACOLOGY, 2005, 16 (5-6): : 405 - 413
  • [5] The cannabinoid CB1 receptor antagonist AM251 does not modify methamphetamine reinstatement of responding
    Boctor, Sherin Y.
    Martinez, Joe L., Jr.
    Koek, Wouter
    France, Charles P.
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2007, 571 (01) : 39 - 43
  • [6] The cannabinoid receptor antagonist AM-251 enhances the cerebrocortical hyperemic response to hypoxia/hypercapnia
    Ishiguro, M
    Lacza, Z
    Horvath, EM
    Jarai, Z
    Sandor, P
    Benyo, Z
    [J]. FASEB JOURNAL, 2004, 18 (04): : A267 - A267
  • [7] Local pretreatment with the cannabinoid CB1 receptor antagonist AM251 attenuates methamphetamine intra-accumbens self-administration
    Rodriguez, Jesse S.
    Boctor, Sherin Y.
    Flores, Luke C.
    Phelix, Clyde F.
    Martinez, Joe L., Jr.
    [J]. NEUROSCIENCE LETTERS, 2011, 489 (03) : 187 - 191
  • [8] THE CANNABINOID 1 RECEPTOR ANTAGONIST AM251 ALTERS THE KYOTORPHIN EFFECT ON DENSITY OF CB1 IMMUNOPOSITIVE NEURONS IN THE AMYGDALA
    Landzhov, Boycho
    Malinova, Lina
    Kartelov, Yuliyan
    Dzhambazova, Elena
    Ovtscharoff, Wladimir
    [J]. COMPTES RENDUS DE L ACADEMIE BULGARE DES SCIENCES, 2014, 67 (08): : 1165 - 1170
  • [9] Antidiabetic effects of sub-chronic administration of the cannabinoid receptor (CB1) antagonist, AM251, in obese diabetic (ob/ob) mice
    Irwin, Nigel
    Hunter, Kerry
    Frizzell, Nonna
    Flatt, Peter R.
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2008, 581 (1-2) : 226 - 233
  • [10] Acute anorectic response to cannabinoid CB1 receptor antagonist/inverse agonist AM 251 in rats: indirect behavioural mediation
    Tallett, Amy J.
    Blundell, John E.
    Rodgers, John R.
    [J]. BEHAVIOURAL PHARMACOLOGY, 2007, 18 (07): : 591 - 600
12345